City Therapeutics, founded by Alnylam's John Maraganore, has raised $99.5 million in Series B funding to advance its ...
Crabtree is not the first time Level99 has paired up with California-based Macerich (NYSE: MAC), as the business also opened ...
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results